Wotnews is an Australian news monitoring service. Register FREE to monitor Biotechnology Industry or Peplin.
Biotechnology Industry or Peplin
Highlights this month
-
Completed its US$6.7 million purchase of private ..
Peplin completes Neosil buy
A daily e-mail from Australian Biotechnology News, with the latest, most important headlines from Australia and around the world. Peplin has completed its US$6.7 million purchase of private ...
Life Scientist - 1 month, 1 week ago
-
Begun phase three clinical trials of its skin cancer gel ...
Trial for sun spot gel
BIOTECH company Peplin has begun phase three clinical trials of its skin cancer gel for the treatment of sun spots and pre-cancerous lesions.
The Australian Business News - 2 months, 3 weeks ago
-
Launched the next phase in its clinical trials of a ...
Peplin salve a step closer
PHARMACEUTICAL company Peplin has launched the next phase in its clinical trials of a weed - derived gel for the treatment of pre - cancerous skin lesions.The trial will use ...
The Age - 5 months, 1 week ago
-
Returning to its shareholders for a third time to get ...
Peplin fretting for float
Australian skin cancer researcher Peplin is returning to its shareholders for a third time to get approval to launch on the Nasdaq, but this time it is a step closer, ...
The Age - 8 months, 1 week ago
-
Renewed investor approval for a US float after holding off ...
Peplin revives float bid
AUSTRALIAN skin cancer researcher Peplin has renewed investor approval for a US float after holding off a Nasdaq listing for the past three months.
Herald Sun - 10 months, 2 weeks ago
-
Shifting its parent company to the US, contrasting with statements ...
Biotech vows 'to stay local'
Biotechnology group Peplin is shifting its parent company to the US, contrasting with statements a year ago to remain an Australian company.
Courier Mail Business News - 1 year, 3 months ago
1 hour, 4 minutes ago
Tilbrook to step down from Wesfarmers
Wesfarmers finance director Gene Tilbrook has decided to step down from the company after 23 years of service. The diversified company said in a statement that Mr Tilbrook will retire ...
WA Business News - 11:23 a.m. Tuesday 2nd December 2008
WA Business News - 11:23 a.m. Tuesday 2nd December 2008
Wesfarmers' finance director to step down
Wesfarmers Limited (WES) said finance director Gene Tilbrook would retire in the first half of 2009. The company said Terry Bowen, currently finance director of the Coles division, would replace ...
ninemsn Money - 10:57 a.m. Tuesday 2nd December 2008
ninemsn Money - 10:57 a.m. Tuesday 2nd December 2008
Peplin director buys off-market
Peplin director buys off-market... 02 Dec 2008 11:54 AM
Business Spectator health & pharmaceuticals - 10:54 a.m. Tuesday 2nd December 2008
Business Spectator health & pharmaceuticals - 10:54 a.m. Tuesday 2nd December 2008
Wesfarmers' finance director to step down
Wesfarmers Limited (WES) said finance director Gene Tilbrook would retire in the first half of 2009. The company said Terry Bowen, currently finance director of the Coles division, would replace ...
Live News Business - 10:28 a.m. Tuesday 2nd December 2008
Live News Business - 10:28 a.m. Tuesday 2nd December 2008
Peplin ready to begin phase III testing
Peplin Incorporated (PLI) said as of the quarter ended 30 September 2008, it had a pro-forma cash position of US$43.6 million ($68.2 million). The company said that as a result ...
ninemsn Money - 9:53 a.m. Tuesday 2nd December 2008
ninemsn Money - 9:53 a.m. Tuesday 2nd December 2008
Peplin ready to begin phase III testing
Peplin Incorporated (PLI) said as of the quarter ended 30 September 2008, it had a pro-forma cash position of US$43.6 million ($68.2 million). The company said that as a result ...
Live News Business - 9:26 a.m. Tuesday 2nd December 2008
Live News Business - 9:26 a.m. Tuesday 2nd December 2008
Wesfarmers finance director announces retirement
Gene Tilbrook to step down in the first half of 2009, after 23 years with conglomerate. 2 Dec 2008 10:11 AM
Business Spectator resources & energy - 9:11 a.m. Tuesday 2nd December 2008
Business Spectator resources & energy - 9:11 a.m. Tuesday 2nd December 2008
Air New Zealand Postpones Biofuel Test Flight to Focus Attention on A320 Crash
Air New Zealand has postponed its biofuel test flight and its pre-flight briefing which were set to take place on Wednesday 3 December and 2 December respectively.
etravelblackboard - 8:54 a.m. Tuesday 2nd December 2008
etravelblackboard - 8:54 a.m. Tuesday 2nd December 2008
Historic Biofuel Flight Crosses USA
"These flights prove that we have the capability of supplementing our energy requirements with safe, environmentally-friendly alternatives to petroleum"
TravelMole - 7:51 a.m. Tuesday 2nd December 2008
TravelMole - 7:51 a.m. Tuesday 2nd December 2008
Sleep terrors may have genetic roots (Reuters)
NEW YORK (Reuters Health) - Sleep terrors may run in the family, new research in twins shows.
Yahoo!7 - Technology - 6:40 a.m. Tuesday 2nd December 2008
Yahoo!7 - Technology - 6:40 a.m. Tuesday 2nd December 2008
Some links for light reading (2/12/08)
UXBookClub IE 6 mobile standards compliance tests Helvetireader Genetic A/B Testing with JavaScript Web content migration: disastrous strategy Pretending to be the blind guy Processing 1.0 s3Slider jQuery plugin Review: ...
MaxDesign - 6:30 a.m. Tuesday 2nd December 2008
MaxDesign - 6:30 a.m. Tuesday 2nd December 2008
Johnson & Johnson buying Mentor
Health care products company Johnson Johnson said it will buy cosmetic-product and breast-implant maker Mentor Corp for $US1.
Sky News Business - 4:32 a.m. Tuesday 2nd December 2008
Sky News Business - 4:32 a.m. Tuesday 2nd December 2008
J&J to buy breast implant firm Mentor for $US1.1bn
Diversified health care giant pushes into cosmetic medical procedures market. 2 Dec 2008 4:47 AM
Business Spectator health & pharmaceuticals - 3:47 a.m. Tuesday 2nd December 2008
Business Spectator health & pharmaceuticals - 3:47 a.m. Tuesday 2nd December 2008
12 hours, 53 minutes ago
Prana Provides Update on Research and Development Programs at AGM
MELBOURNE, AUSTRALIA--(Marketwire - December 1, 2008) - Prana Biotechnology Limited ( NASDAQ : PRAN) ( ASX : PBT) today provided an update of highlights of current and future activities of ...
marketwire - 11:35 p.m. Monday 1st December 2008
marketwire - 11:35 p.m. Monday 1st December 2008
